|
37
|
|
Molecular Imaging of EGFR-Expressing Tumors with Novel Targeted Protein Scaffold, anti-EGFR Repebody
|
Jung-Joon Min, Misun Yun, AYoung Pyo, Hyeon-Sik Kim, Zheng Jinhai, Dong-Yeon Kim, Hee-Seung Bom
|
|
36
|
- 학회명
-
AOJNMB Asia Oceania Journal of Nuclear Medicine & Biology
- 발표제목
-
Left ventricular mechanical dyssynchrony measured using myocardial SPECT predicts cardiac events in acute myocardial infarction with multi-vessel disease
- 발표자
-
Sang-Geon Cho, Ki Seong Park, Sae-Ryung Kang, Jong Sang Kim, Seran Min, Jahae Kim, Ho-Cun Song, Jae Yeong Cho, Kye Hun Kim, Minchul Song, Geum-Cheol Jeong, Hee Jeong Park, Young Jae Kim, Seong Young Kwon, Jung-Joon Min, Hee-Seung Bom
|
Left ventricular mechanical dyssynchrony measured using myocardial SPECT predicts cardiac events in acute myocardial infarction with multi-vessel disease
|
Sang-Geon Cho, Ki Seong Park, Sae-Ryung Kang, Jong Sang Kim, Seran Min, Jahae Kim, Ho-Cun Song, Jae Yeong Cho, Kye Hun Kim, Minchul Song, Geum-Cheol Jeong, Hee Jeong Park, Young Jae Kim, Seong Young Kwon, Jung-Joon Min, Hee-Seung Bom
|
|
35
|
|
Comparison between Tumor heterogeneity and PET imaging features in non-small cell lung cancer
|
H. Kim, S. Kang, B. Lee, H. Bom, J. Min
|
|
34
|
|
Radiosynthesis and In Vivo evaluation of 64Cu Labeled Repebody for EGFR-mediated tumor Imagingin Small Animals
|
A. Pyo, M. Yun, H. Kim, D. Kim, J. Min
|
|
33
|
|
Antibody mimics, fibronectin domain III for EphA2-targeting as a probe in murine tumor model
|
S. Park, Y. Hong, S. Park, Y. Park, R. Kimura, J. Min, S. S. Gambhir
|
|
32
|
|
Identification of the Role of Autophagy in Salmonellae-mediated Cancer Imaging and Therapy
|
M. T. Duong, V. H. Nguyen, T. X. Phan, E. Jo, J. Min
|
|
31
|
|
PET Imaging of Tumor-Targeting Salmonella typhimurium using [18F]Fluorodeoxysorbitol in small animal models
|
D. Kim, V. H. Nguyen, H. Kim, A. Pyo, H. Bom, J. Min
|
|
30
|
|
Visualization of colon and NSCL cancer using Novel Protein Scaffold, anti-EGFR Repebody
|
M. Yun, D. Kim, H. Kim, Z. Jinhai, A. Pyo, Y. Hong, J. Min
|
|
29
|
|
Metastatic central lymph node ratio and predict the malignant potential of FDG-avid lymph nodes in papillary thyroid cancer patients.
|
S. Kwon, J. Kim, S. Kang, S. Jeon, H. Song, H. Bom, J. Min
|
|
28
|
|
Diagnostic performance of C-11 methionine PET using regularized image reconstruction for the prediction of malignant potential in brain tumor
|
S. Kwon, J. Kim, S. Kang, K. Park, H. Sheen, J. Min, H. Song, H. Bom
|
|
27
|
|
Intratumoral metabolic heterogeneity can be useful to select patients for radiotherapy dose-escalation in stage III non-small cell lung cancer
|
S. Kang, H. Kim, K. Park, G. Jeong, H. Park, J. Kim, J. Min
|
|
26
|
|
Clinical implication of preablation thyroglobulin level in differentiated thyroid carcinoma patients underwent recombinant human thyrotropin aided ablative radioiodine treatment
|
H. Park, S. Cho, S. Kang, K. Park, G. Jeong, J. Kim, S. Kwon, J. Min, H. Song, H. Bom
|
|
25
|
|
In vivo imaging of hemoglobin and melanin variations using photoacoustic tomography.
|
H. Kim, V. H. Nguyen, H. Bom, J. Min
|
|
24
|
|
Antibody mimics, fibronectin domain III for EphA2-targeting as a prob in murine tumor model.
|
S. Park, Y. Hong, S. Park, R. H. Kimura, J. Min, S. S. Gambhir
|
|
23
|
|
Molecular Imaging of EGFR-Expressing Tumors with Novel Targeted Protein Scaffold, anti-EGFR Repebody.
|
M. Yun, D. Kim, H. Kim, J. Zheng, A. Pyo, Y. Hong, H. Bom, J. Min
|
